Skip to main content

CCN family of proteins: critical modulators of the tumor cell microenvironment

Journal of Cell Communication and Signaling volume 10, pages 229–240 (2016)Cite this article

Abstract

The CCN family of proteins consisting of CCN1 (Cyr61), CCN2 (CTGF), CCN3 (NOV), CCN4 (WISP-1), CCN5 (WISP-2) and CCN6 (WISP-3) are considered matricellular proteins operating essentially in the extracellular microenvironment between cells. Evidence has also been gradually building since their first discovery of additional intracellular roles although the major activity is triggered at the cell membrane. The proteins consist of 4 motifs, a signal peptide (for secretion} followed consecutively by the IGFBP, VWC, TSP1 and CT (C-terminal cysteine knot domain) motifs, which signify their potential binding partners and functional connections to a variety of key regulators of physiological processes. With respect to cancer it is now clear that, whereas certain members can facilitate tumor behavior and progression, others can competitively counter the process. It is therefore clear that the net outcome of biological interactions in the matrix and what gets signaled or inhibited can be a function of the interplay of these CCN 1–6 proteins. Because the CCN proteins further interact with other key proteins, like growth factors in the matrix, the balance is not only important but can vary dynamically with the physiological states of tumor cells and the surrounding normal cells. The tumor niche with its many cell players has surfaced as a critical determinant of tumor behavior, invasiveness, and metastasis. It is in this context that CCN proteins should be investigated with the potential of being recognized and validated for future therapeutic approaches.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  • Aguiar DP, de Farias GC, de Sousa EB, de Mattos Coelho-Aguiar J, Lobo JC, Casado PL, Duarte ME, Abreu JG Jr (2014) New strategy to control cell migration and metastasis regulated by CCN2/CTGF. Cancer Cell Int 14:61

    Article  PubMed  PubMed Central  Google Scholar 

  • Akalay I, Tan TZ, Kumar P, Janji B, Mami-Chouaib F, Charpy C, Vielh P, Larsen AK, Thiery JP, Sabbah M, Chouaib S (2015) Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression. Oncogene 34:2261–2271

  • Banerjee SK, Banerjee S (2012) CCN5/WISP-2: a micromanager of breast cancer progression. J Cell Commun Signal 6:63–71

    Article  PubMed  PubMed Central  Google Scholar 

  • Bartel F, Balschun K, Gradhand E, Strauss HG, Dittmer J, Hauptmann S (2012) Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary. Int J Gynecol Pathol 31:405–415

    CAS  Article  PubMed  Google Scholar 

  • Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M, Parenza M, Martinez V, Picci P, Scotlandi K (2005) In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24:4349–4361

    CAS  Article  PubMed  Google Scholar 

  • Bhavani GS, Shah H, Dalal AB, Shukla A, Danda S, Aggarwal S, Phadke SR, Gupta N, Kabra M, Gowrishankar K, Gupta A, Bhat M, Puri RD, Bijarnia-Mahay S, Nampoothiri S, Mohanasundaram KM, Rajeswari S, Kulkarni AM, Kulkarni ML, Ranganath P, Ramadevi AR, Hariharan SV, Girisha KM (2015) Novel and Recurrent mutations in WISP3 and an atypical phenotype. Am J Med Genet Part A 167 A:2481–2484

    Article  Google Scholar 

  • Bleau AM, Planque, Perbal B (2005) CCN proteins and cancer: two to tango. Front Biosci 10:998–1009

    CAS  Article  PubMed  Google Scholar 

  • Chang C-C, Yang M-H, Lin B-R, Chen S-T, Pan S-H, Hsiao M, Lai T-C, Lin S-K, Jeng Y-M, Chu C-Y, Chen R-H, Yang P-C, Chin YE, Kuo M-L (2013) CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation. Cell Death Differ 20:443–455

    CAS  Article  PubMed  Google Scholar 

  • Chang C-C, Lin B-R, T-S W, Jeng Y-M, Kuo M-L (2014) Input of microenvironmental regulation on colorectal cancer: role of the CCN family. World J Gastroenterol 20:6826–6831

    Article  PubMed  PubMed Central  Google Scholar 

  • Chang C-H, T-T O, Yang M-Y, Huang C-C, Wang C-J (2016) Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling. J Ethnopharmacol 188:111–122

    CAS  Article  PubMed  Google Scholar 

  • Chen P-C, Lin T-H, Cheng H-C, Tang C-H (2012) CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells. Carcinogenesis 33:937–945

    CAS  Article  PubMed  Google Scholar 

  • Chen J, Gao Y, Xu B, Cui X, Xu D (2014a) NOV is upregulated and promotes migration and invasion in bladder cancer. Tumor Biol 35:6749–6755

    CAS  Article  Google Scholar 

  • Chen J, Yin J, Li X, Wang Y, Zheng Y, Qian C, Xiao L, Zou T, Wang Z, Liu J, Zhang W, Zhou H, Liu Z (2014b) WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients. Int J Mol Sci 15:21011–21027

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Chen L, Charrier A, Zhou Y, Chen R, Yu B, Agarwal K, Tsukamoto H, Lee LJ, Paulaitis ME, Brigstock DR (2014c) Epigenetic regulation of connective tissue growth factor by microRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 59:1118–1129

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Chen J, Yin J-Y, Li X-P, Wang Y, Zheng Y, Qian C-Y, Fang C, Wang Z, Zhang Y, Xiao L, Wang S-Y, Zhang W, Zhou H-H, Liu Z-Q (2015) Association of Wnt-Inducible signaling pathway protein 1 genetic polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Clin Lung Cancer 16:298–304

    CAS  Article  PubMed  Google Scholar 

  • Chiang K-C, Yeh C-N, Chung L-C, Feng T-H, Sun C-C, Chen M-F, Jan Y-Y, Yeh T-S, Chen S-C, Juang H-H (2015) WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer. Sci Rept 5:8686

    CAS  Article  Google Scholar 

  • Chintalapudi MR, Markiewicz M, Kose N, Dammai V, Champion KJ, Hoda RS, Trojanowska M, Hsu T (2008) Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells. Carcinogenesis 29:696–703

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Chong HC, Tan CK, Huang R-L, Tan NS (2012) Matricellular proteins: a sticky affair with cancers. J Oncol 2012:351089

    Article  PubMed  PubMed Central  Google Scholar 

  • Chuang J-Y, Chen P-C, Tsao C-W, Chang A-C, Lein M-Y, Lin C-C, Wang S-W, Lin C-W, Tang C-H (2015) WISP-1, a novel angiogenic regulator of the CCN family, promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression. Oncotarget 6:4239–4252

    Article  PubMed  PubMed Central  Google Scholar 

  • Cicha I, Goppelt-Struebe M (2009) Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors 35:200–208

    CAS  Article  PubMed  Google Scholar 

  • Cui L, Xie R, Dang S, Zhang Q, Mao S, Chen J, Qu J, Zhang J (2014) NOV promoted the growth and migration of pancreatic cancer cells. Tumor Biol 35:3195–3201

    CAS  Article  Google Scholar 

  • Emre Y, Imhof BA (2014) Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking. Semin Immunopathol 36:253–259

    CAS  Article  PubMed  Google Scholar 

  • Fang F, Zhao W-Y, Li R-K, Yang X-M, Li J, Ao J-P, Jiang S-H, Kong F-Z, Tu L, Zhuang C, Qin W-X, He P, Zhang W-M, Cao H, Zhang Z-G (2014) Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling. Int J Clin Exp Pathol 7:6447–6461

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ferrand N, Gnanapragasam A, Dorothee G, Redeuilh G, Larsen AK, Sabbah M (2014) Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype. PLoS One 9: e87878

  • Frewer KA, Sanders AJ, Owen S, Frewer NC, Hargest R, Jiang G (2013) A role for WISP2 in colorectal cancer cell invasion and motility. Cancer Genomics Proteomics 10:187–196

    CAS  PubMed  Google Scholar 

  • Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, Winterhager E (2004) Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279:36931–36942

    CAS  Article  PubMed  Google Scholar 

  • Gilkes DM, Semeza GL, Wirtz D (2014) Hypoxia and the extracellular matrix: drivers of tumour metastases. Nat Rev Cancer 14:430–439

  • Glukhova L, Angevin E, Lavialle C, Cadot B, Terrier-Lacombe MJ, Perbal B, Bernheim A, Goguel AF (2001) Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas. Cancer Genet Cytogenet 130:105–110

    CAS  Article  PubMed  Google Scholar 

  • Gonzalez-Guerrico AM, Espinoza I, Schroeder B, Park CH, Mohan KVPC, Khurana A, Corominas-Faja B, Cuyàs E, Alarcón T, Kleer C, Menendez JA, Lupu R (2016) Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer. Oncotarget 7:1–18

  • Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, Yu J, Perbal B, Weichselbaum RR (2001) Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54:293–299

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Gurbuza I, Chiquet-Ehrismann R (2015) CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer. Int J Biochem Cell Biol 62:142–146

    Article  Google Scholar 

  • Haque I, De A, Majumder M, Mehta S, McGregor D, Banerjee SK, Van Veldhuizen P, Banerjee S (2012) The matricellular protein CCN1/Cyr61 is a critical regulator of sonic hedgehog in pancreatic carcinogenesis. J Biol Chem 287:38569–38579

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Hara, C, Kubota, S, Nishida, T, Hiasa, M, Hattori, T, Aoyama, E ,Moriyama, Y, Kamioka, H, Takigawa, M (2016) Involvement of multiple CCN family members in platelets that support regeneration of joint tissues. Mod Rheumatol 21:1–10

  • Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: structure–function relationships. Trends Biochem Sci 33:461–473

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Huang Y-T, Lan Q, Ponsonnet L, Blanquet M, Christofori G, Zaric J, Rüegg C (2016a) The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression. Oncotarget 7:1663–1674

    PubMed  Google Scholar 

  • Huang W, Martin EE, Burman B, Gonzalez ME, Kleer CG (2016b) The matricellular protein ccn6 (WISP3) decreases notch1 and suppresses breast cancer initiating cells. Oncotarget 7:25180–25193

    PubMed  Google Scholar 

  • Hutchenreuther J, Vincent KM, Carter DE, Postovit LM, Leask A (2015) CCN2 expression by tumor stroma is required for melanoma metastasis. J Invest Dermatol 135:2805–2813

    CAS  Article  PubMed  Google Scholar 

  • Ishida J, Kurozumi K, Ichikawa T, Otani Y, Onishi M, Fujii K, Shimazu Y, Oka T, Shimizu T, Date I (2015) Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma. Brain Tumor Pathol 32:245–252

    CAS  Article  PubMed  Google Scholar 

  • Jandova J, Beyer TE, Meuillet EJ, Watts GS (2012) The matrix protein CCN1/CYR61 is required for αVβ5-mediated cancer cell migration. Cell Biochem Funct 30:687–695

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Jeong D, Heo S, Ahn TS, Lee S, Park S, Kim H, Park D, Bae SB, Lee SS, Lee MS, Kim C-J, Baek MJ (2014) Cyr61 expression is associated with prognosis in patients with colorectal cancer. BMC Cancer 14:164

    Article  PubMed  PubMed Central  Google Scholar 

  • Ji, J, Jia, S, Ji, K, Jiang, WG (2014) Wnt1 inducible signaling pathway protein-2 (WISP-2/CCN5): roles and regulation in human cancers (Review). Oncol Rept 31:533–539

  • Ji J, Jia S, Jia Y, Ji K, Hargest R, Jiang WG (2015) WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-c pathways. Brit. J Cancer 113:921–933

    CAS  Article  Google Scholar 

  • Jia Q, Dong Q, Qin L (2016) CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma? Oncotarget 7:1203–1214

    PubMed  Google Scholar 

  • Kawaki H, Kubota S, Suzuki A, Lazar N, Yamada T, Matsumura T, Ohgawara T, Maeda T, Perbal B, Lyons KM, Takigawa M (2008) Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage. J Bone Miner Res 23:1751–1764

    CAS  Article  PubMed  Google Scholar 

  • Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I (2007) Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res 67:7095–7105

    CAS  Article  PubMed  Google Scholar 

  • Kim GJ, Rhee H, Yoo JE, Ko JE, Lee JS, Kim H, Choi JS, Park YN (2014) Increased expression of CCN2, epithelial membrane antigen, and fibroblast activating factor in hepatocellular carcinoma with fibrous stroma showing aggressive behavior. PLoS One 9:e105094

    Article  PubMed  PubMed Central  Google Scholar 

  • Klinke DJ II (2014) Induction of wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study. PLoS Comput Biol 10:e1003409

    Article  PubMed  Google Scholar 

  • Krupska I, Bruford EA, Chaqour B (2015) Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities. Hum Genomics 9:24

  • Kubota S, Takigawa M (2015) Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions. Clin Sci 128:181–196

    CAS  Article  PubMed  Google Scholar 

  • Lacle MM, van Diest PJ, Goldschmeding R, van der Wall E, Nguyen TQ (2015) Expression of connective tissue growth factor in male breast cancer: clinicopathologic correlations and prognostic value. PLoS One 10:e0118957

    Article  PubMed  PubMed Central  Google Scholar 

  • Lau LF (2011) CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 68:3149–3163

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Lau LF (2016) Cell surface receptors for CCN proteins. J Cell Commun Signal 10:121–127

    Article  PubMed  PubMed Central  Google Scholar 

  • Leal LF, Mermejo LM, Ramalho LZ, Martinelli CE Jr, Yunes JA, Seidinger AL, Mastellaro MJ, Cardinalli IA, Brandalise SR, Moreira AC, Tone LG, Scrideli CA, Castro M, Antonini SR (2011) Wnt/β-catenin pathway deregulation in childhood adrenocortical tumors. J Clin Endocrinol Metab 96:3106–3114

    CAS  Article  PubMed  Google Scholar 

  • Lecot P, Alimirah F, Desprez P-Y, Campisi J, Wiley C (2016) Context-dependent effects of cellular senescence in cancer development. Br J Cancer 114:1180–1184

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Li W-F, Zhang L, Li H-Y, Zheng S-S, Zhao L (2014) WISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice. PLoS One 9:e94751

    Article  PubMed  PubMed Central  Google Scholar 

  • Li J, Ye L, Owen S, Weeks HP, Zhang Z, Jiang WG (2015) Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). Int J Mol Med 36:1451–1463

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lin C-C, Chen P-C, Lein M-Y, Tsao C-W, Huang C-C, Wang S-W, Tang C-H, Tung K-C (2016) WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells. Oncotarget 7:1993–10005

    Google Scholar 

  • Liu S-C, Lee H-P, Hung C-Y, Tsai C-H, Li T-M, Tang C-H (2015) Berberine attenuates CCN2-induced IL-1β expression and prevents cartilage degradation in a rat model of osteoarthritis. Toxicol Appl Pharmacol 289:20–29

    CAS  Article  PubMed  Google Scholar 

  • Long Q-Z, Zhou M, Liu X-G, Y-F D, Fan J-H, Lia X, He D-L (2013) Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells. Anti-Cancer Drugs 24:810–817

    CAS  Article  PubMed  Google Scholar 

  • Lorenzatti G, Huang W, Pal A, Cabanillas AM, Kleer CG (2011) CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J Cell Sci 124:1752–1758

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Maillard M, Cadot B, Ball RY, Sethia K, Edwards DR, Perbal B, Tatoud R (2001) Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol 54:275–280

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Malta DFB, Reticker-Flynn NE, da Silva CL, Cabral JMS, Fleming HE, Zaret KS, Bhatia SN, Underhill GH (2016) Extracellular matrix microarrays to study inductive signaling for endoderm specification. Acta Biomater 34:30–40

    CAS  Article  Google Scholar 

  • Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami J, Yeger H, Picci P, Scotlandi K (2002) The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol 160:849–859

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • McCallum L, Price S, Planque N, Perbal B, Pierce A, Whetton AD, Irvine AE (2006) A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood 108:1716–1723

    CAS  Article  PubMed  Google Scholar 

  • McCallum L, Lu W, Price S, Lazar N, Perbal B, Irvine AE (2009) CCN3: a key growth regulator in chronic myeloid leukaemia. J Cell Commun Signal 3:115–124

    Article  PubMed  PubMed Central  Google Scholar 

  • Meng X-M, Nikolic-Paterson DJ, Lan HY (2016) TGF-β: the master regulator of fibrosis. Nat Rev Nephrol 12:325–338

    CAS  Article  PubMed  Google Scholar 

  • Morales MG, Gutierrez J, Cabello-Verrugio C, Cabrera D, Lipson KE, Goldschmeding R, Brandan E (2013) Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy. Hum Mol Genet 22:4938–4951

    CAS  Article  PubMed  Google Scholar 

  • Murphy-Ullrich JE, Sage EH (2014) Revisiting the matricellular concept. Matrix Biol 37:1–14

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Nieto, MA, Huang, RY-J, Jackson, RA, Thiery, JP (2016) EMT: 2016. Cell 166: 21–45.

  • Ono M, Inkson CA, Sonn R, Kilts TM, de Castro LF, Maeda A, Fisher LW, Robey PG, Berendsen AD, Li L, McCartney-Francis N, Brown AC, Crawford NPS, Molinolo A, Jain A, Fedarko NS, Young MF (2013) WISP1/CCN4: A Potential Target for inhibiting prostate cancer growth and spread to bone. PLoS ONE 8(8):e71709

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Pal A, Huang W, Li X, Toy KA, Nikolovska-Coleska Z, Kleer CG (2012a) CCN6 modulates BMP signaling via the smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer. Cancer Res 72:4818–4828

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Pal A, Huang W, Toy KA, Kleer CG (2012b) CCN6 knockdown disrupts acinar organization of breast cells in three-dimensional cultures through upregulation of type II TGF-β receptor. Neoplasia 14:1067–1074

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Patel P, Brooks C, Seneviratne A, Hess DA, Seguin CA (2014) Investigating microenvironmental regulation of human chordoma cell behavior. PLoS ONE 9:e115909

    Article  PubMed  PubMed Central  Google Scholar 

  • Patraa, M, Mahatab, SK, Padhana, DK, Sena, M (2016) CCN6 (Wnt induced signaling protein – 3) regulates mitochondrial function. Cell Sci Advanced June 1, 2016

  • Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A 95:14717–14722

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Perbal B (1999) Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression. Mol Pathol 52:84–91

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Perbal B (2001) NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 54:57–79

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Perbal B (2006) New insight into CCN3 interactions--nuclear CCN3 : fact or fantasy? Cell Commun Signal 4:6.

  • Perbal B (2013) CCN proteins: a centralized communication network. J Cell Commun Signal 7:169–177

    Article  PubMed  PubMed Central  Google Scholar 

  • Perbal B, Zuntini M, Zambelli D, Serra M, Sciandra M, Cantiani L, Lucarelli E, Picci P, Scotlandi K (2008) Prognostic value of CCN3 in osteosarcoma. Clin Cancer Res 14:701–709

    CAS  Article  PubMed  Google Scholar 

  • Perbal B, Lau L, Lyons K, Kubota S, Yeger H, Fisher G (2016) Report on the 8th international workshop on the CCN family of genes – Nice November 3–8, 2015. J Cell Commun Signal 10:77–86

    Article  PubMed  PubMed Central  Google Scholar 

  • Piszczatowski RT, Lents NH (2016) Regulation of the CCN genes by vitamin D: a possible adjuvant therapy in the treatment of cancer and fibrosis. Cell Signal 28:1604–1613.

  • Rachfal AW, Luquette MH, Brigstock DR (2004) Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour. J Clin Pathol 57:422–425

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Rayego-Mateos S, Rodrigues-Diez R, Morgado-Pascual JL, Rodrigues Diez RR, Mas S, Lavoz C, Alique M, Pato J, Keri G, Ortiz A, Egido J, Ruiz-Ortega M (2013) Connective tissue growth factor is a new ligand of epidermal growth factor receptor. J Mol Cell Biol 5:323–335

    CAS  Article  PubMed  Google Scholar 

  • Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, Riser ML, Sukowski E, Yeger H, Riser SC (2009) CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol 174:1725–1734

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Rodrigues-Diez RR, Garcia-Redondo AB, Orejudo M, Rodrigues-Diez R, Briones AM, Bosch-Panadero E, Kery G, Pato J, Ortiz A, Salaices M, Egido J, Ruiz-Ortega M (2015) The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-kB pathway and proinflammatory factors in vascular smooth muscle cells. Antioxid Redox Signal 22:29–48

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Russo JW, Castellot JJ Jr (2010) CCN5: biology and pathophysiology. J Cell Commun Signal 4:119–130

    Article  PubMed  PubMed Central  Google Scholar 

  • Saglam O, Dai F, Husain S, Zhan Y, Toruner G, Haines IIIGK (2014) Matricellular protein CCN1 (CYR61) expression is associated with high-grade ductal carcinoma in situ. Hum Pathol 45:1269–1275

    CAS  Article  PubMed  Google Scholar 

  • Schlegelmilch K, Keller A, Zehe V, Hondke S, Schilling T, Jakob F, Klein-Hitpass L, Schütze N (2014) WISP 1 is an important survival factor in human mesenchymal stromal cells. Gene 551:243–254

    CAS  Article  PubMed  Google Scholar 

  • Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H (2015) Cancer –associated fibroblasts: their characteristics and their roles in tumor growth. Cancers (Basel) 7:2443–2458

    Article  Google Scholar 

  • Suresh S, McCallum L, Crawford LJ, WH L, Sharpe DJ, Irvine AE (2013) The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia. J Pathol 231:378–387

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Tai H-C, Chang A-C, H-J Y, Huang C-Y, Tsai Y-C, Lai Y-W, Sun H-L, Tang C-H, Wang S-W (2014) Osteoblast-derived WISP-1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126. Oncotarget 5:7589–7598

    Article  PubMed  PubMed Central  Google Scholar 

  • Tsai H-C, Huang C-Y, Su H-L, Tang C-H (2014) CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma. PLoS One 9: e90159

  • Ueda M, Iguchi T, Komatsu H, Kidogami S, Hu Q, Sato K, Ogawa J, Nambara S, Saito T, Sakimura S, Hirata H, Uchi R, Shinden Y, Eguchi H, Ito S, Masuda T, Yamamoto H, Doki Y, Mori M, Mimori K (2015) Clinical significance of expression of nephroblastoma overexpressed (NOV) in patients with colorectal cancer. Anticancer Res 35:6591–6598

    CAS  PubMed  Google Scholar 

  • Vallacchi V, Daniotti M, Ratti F, Di Stasi D, Deho P, De Filippo A, Tragni G, Balsari A, Carbone A, Rivoltini L, Parmiani G, Lazar N, Perbal B, Rodolfo M (2008) CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma. Cancer Res 68:715–723

    CAS  Article  PubMed  Google Scholar 

  • Wagener J, Yang W, Kazuschke K, Winterhager E, Gellhaus A (2013) CCN3 regulates proliferation and migration properties in Jeg3 trophoblast cells via ERK1/2, Akt and Notch signaling. Mol Hum Reproduct 19:237–249

    CAS  Article  Google Scholar 

  • Wallace DM, Clark AF, Lipson KE, Andrews D, Crean JK, O’Brien CJ (2013) Anti-connective tissue growth factor antibody treatment reduces extracellular matrix production in trabecular meshwork and lamina cribrosa cells. Invest Ophthalmol Vis Sci 54:7836–7848

    CAS  Article  PubMed  Google Scholar 

  • Wells JE, Howlett M, Cole CH, Kees UR (2015a) Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer. Int. J. Cancer 137:504–511

    CAS  Article  PubMed  Google Scholar 

  • Wells JE, Howlett M, Cheung LC, Kees UR (2015b) The role of CCN family genes in haematological malignancies. J Cell Commun Signal 9:267–278

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Wu L, Runkle C, Jin H-J, Yu J, Li J, Yang X, Kuzel T, Lee C, Yu J (2014) CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor. Oncogene 33:504–513

    CAS  Article  PubMed  Google Scholar 

  • Xu H, Li P, Liu M, Liu C, Sun Z, Guo X, Zhang Y (2015) CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β. Clin Exp Pharmacol Physiol 42:1207–1219

    CAS  Article  PubMed  Google Scholar 

  • Yang Z, Yang Z, Zou Q, Yuan Y, Li J, Li D, Liang L, Zeng G, Chen S (2014) A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder. Int J Clin Oncol 19:325–335

    CAS  Article  PubMed  Google Scholar 

  • Yao J, Weng Y, Yan S, Hou M, Wang H, Shi Q, Zuo G (2015) NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/.MAPK pathways. Oncol Rept 34:2011–2023

    Google Scholar 

  • Yeger H, Perbal B (2007) The CCN family of genes: a perspective on CCN biology and therapeutic potential. J Cell Commun Signal 1:159–164

    Article  PubMed  Google Scholar 

  • Zeng J, Liao Y, Zhou J, Yang G, Ding K, Zhang X (2015) Role of WISP3 siRNA in proliferation, apoptosis and invasion of bladder cancer cells. Int J Clin Exp Med 8:12792–12800

    PubMed  PubMed Central  Google Scholar 

  • Zhang H, Luo H, Hu Z, Peng J, Jiang Z, Song T, Wu B, Yue J, Zhou R, Xie R, Chen T, Wu S (2015a) Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation. Oncotarget 6:6218–6234

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang H, Li W, Huang P, Lin L, Ye H, Lin D, Koeffler HP, Wang J, Yin D (2015b) Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma. Oncol Rept 33:1481–1492

    Google Scholar 

Download references

Author information

Affiliations

  1. Program in Developmental & Stem Cell Biology, Research Institute, The Hospital for Sick Children, Toronto, Canada

    Herman Yeger

  2. CNRS, GREDEG, International CCN Society, Université Côte d’Azur, Côte d’Azur, France

    Bernard Perbal

Authors
  1. Herman Yeger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernard Perbal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Herman Yeger.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yeger, H., Perbal, B. CCN family of proteins: critical modulators of the tumor cell microenvironment. J. Cell Commun. Signal. 10, 229–240 (2016). https://doi.org/10.1007/s12079-016-0346-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12079-016-0346-6

Keywords

  • CCN proteins
  • Cancer